The US FDA has given accelerated approval to Jazz Pharma for Modeyso to treat adult and paediatric patients with diffuse midline glioma.

Most Americans get more than half their calories from ultraprocessed foods, those super-tasty, energy-dense foods typically full of sugar, salt and unhealthy fats, according to a new federal report.

Scientists have discovered that low levels of lithium, a metal that has long been used to treat mood disorders, could be causing Alzheimer's disease ...

In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the ...

Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...

Hour Energy. She thought it was harmless. But for her it wasn't, says the 49-year-old Ohio mom of two.Start the day smarter. Get all the news you need in your inbox each morning.

A Rankin County teenager’s life-changing medication is being denied approval by the U.S. Food and Drug Administration, leaving him and many others with rare diseases unsure of their futures.

The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' drug to treat diffuse ...

The FDA is updating opioid safety labels to support treatment decisions based on the latest evidence to reduce misuse.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story CDC to restore overdose prevention funds ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency ...